Meeting
2024 ASCO Genitourinary Cancers Symposium
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer.
Authors
Sharon Choi
University of California, San Diego, San Diego, CA
Sharon Choi , Elizabeth Pan , Andrew Elliott , Himisha Beltran , Justine Panian , Christina Jamieson , Aditya Bagrodia , Brent S. Rose , Daniel Herchenhorn , Elisabeth I. Heath , Chadi Nabhan , Emmanuel S. Antonarakis , Rana R. McKay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 221)
DOI
10.1200/JCO.2024.42.4_suppl.221
Abstract #
221
Poster Bd #
K9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Characterization and impact of canonical Wnt Signaling Pathway (WSP) alterations on outcomes of metastatic prostate cancer.
First Author: Rana R. McKay
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC).
First Author: Amanda Broderick
Poster
2020 Genitourinary Cancers Symposium
Characterization of Wnt signaling pathway (WSP) aberrations in advanced prostate cancer.
First Author: Fady Ghali
Poster
2019 ASCO Annual Meeting
WNT activating pathway mutations confer resistance to first-line antiandrogen therapy in castration-resistant prostate cancer (CRPC).
First Author: Pedro Isaacsson Velho